Highlight Report: The Pseudolobule in Liver Fibrosis

Overview

Journal EXCLI J

Specialty Biology

Date 2018 Jan 16

PMID 29333134

Citations 4

Authors

H M Bolt

Affiliations

Soon will be listed here.

Citing Articles

Liver fibrosis causes periportalization of lobular zonation.

Seddek A EXCLI J. 2020; 18:1104-1106.

PMID: 31938031 PMC: 6953536. DOI: 10.17179/excli2019-2078.

Highlight report: Toxicogenomics atlas of rat hepatotoxicants.

Seidel F EXCLI J. 2019; 17:1196-1197.

PMID: 30713482 PMC: 6341424. DOI: 10.17179/excli2018-2000.

Highlight report: General determinants of steatosis.

Albrecht W EXCLI J. 2019; 17:1194-1195.

PMID: 30713481 PMC: 6341447. DOI: 10.17179/excli2018-2011.

Highlight report: Necrosis-apoptosis conundrum of hepatocytes: mode of hepatocyte death after acetaminophen intoxication.

Ghallab A EXCLI J. 2019; 17:1191-1193.

PMID: 30713480 PMC: 6341448. DOI: 10.17179/excli2018-2013.

References

Kim J, Fluri D, Marchan R, Boonen K, Mohanty S, Singh P . 3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis. J Biotechnol. 2015; 205:24-35. DOI: 10.1016/j.jbiotec.2015.01.003. View

Hammad S, Braeuning A, Meyer C, Mohamed F, Hengstler J, Dooley S . A frequent misinterpretation in current research on liver fibrosis: the vessel in the center of CCl-induced pseudolobules is a portal vein. Arch Toxicol. 2017; 91(11):3689-3692. DOI: 10.1007/s00204-017-2040-8. View

Schenk A, Ghallab A, Hofmann U, Hassan R, Schwarz M, Schuppert A . Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage. Sci Rep. 2017; 7(1):6224. PMC: 5524914. DOI: 10.1038/s41598-017-04574-z. View

Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou S . Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol. 2017; 91(11):3477-3505. DOI: 10.1007/s00204-017-2045-3. View

Frey O, Misun P, Fluri D, Hengstler J, Hierlemann A . Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis. Nat Commun. 2014; 5:4250. DOI: 10.1038/ncomms5250. View

Nussler A, Wildemann B, Freude T, Litzka C, Soldo P, Friess H . Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis. Arch Toxicol. 2014; 88(4):997-1006. DOI: 10.1007/s00204-013-1191-5. View

Hoehme S, Brulport M, Bauer A, Bedawy E, Schormann W, Hermes M . Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration. Proc Natl Acad Sci U S A. 2010; 107(23):10371-6. PMC: 2890786. DOI: 10.1073/pnas.0909374107. View

Chen R, Wu H, Wang Y . Strategies to prevent and reverse liver fibrosis in humans and laboratory animals. Arch Toxicol. 2015; 89(10):1727-50. DOI: 10.1007/s00204-015-1525-6. View

Vartak N, Damle-Vartak A, Richter B, Dirsch O, Dahmen U, Hammad S . Cholestasis-induced adaptive remodeling of interlobular bile ducts. Hepatology. 2015; 63(3):951-64. PMC: 5066759. DOI: 10.1002/hep.28373. View

10.

Moghbel M, Mashohor S, Mahmud R, Iqbal Bin Saripan M . Automatic liver segmentation on Computed Tomography using random walkers for treatment planning. EXCLI J. 2017; 15:500-517. PMC: 5225683. DOI: 10.17179/excli2016-473. View

11.

Jansen P, Ghallab A, Vartak N, Reif R, Schaap F, Hampe J . The ascending pathophysiology of cholestatic liver disease. Hepatology. 2016; 65(2):722-738. DOI: 10.1002/hep.28965. View

12.

Drasdo D, Hoehme S, Hengstler J . How predictive quantitative modelling of tissue organisation can inform liver disease pathogenesis. J Hepatol. 2014; 61(4):951-6. DOI: 10.1016/j.jhep.2014.06.013. View

13.

Crespo Yanguas S, Willebrords J, Maes M, Da Silva T, Pereira I, Cogliati B . Connexins and pannexins in liver damage. EXCLI J. 2016; 15:177-86. PMC: 4822047. DOI: 10.17179/excli2016-119. View

14.

Reif R, Ghallab A, Beattie L, Gunther G, Kuepfer L, Kaye P . In vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in mice. Arch Toxicol. 2016; 91(3):1335-1352. PMC: 5316407. DOI: 10.1007/s00204-016-1906-5. View

15.

Ghallab A, Celliere G, Henkel S, Driesch D, Hoehme S, Hofmann U . Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases. J Hepatol. 2015; 64(4):860-71. DOI: 10.1016/j.jhep.2015.11.018. View

16.

Bartl M, Pfaff M, Ghallab A, Driesch D, Henkel S, Hengstler J . Optimality in the zonation of ammonia detoxification in rodent liver. Arch Toxicol. 2015; 89(11):2069-78. DOI: 10.1007/s00204-015-1596-4. View

17.

Crespo Yanguas S, Cogliati B, Willebrords J, Maes M, Colle I, Van den Bossche B . Experimental models of liver fibrosis. Arch Toxicol. 2015; 90(5):1025-1048. PMC: 4705434. DOI: 10.1007/s00204-015-1543-4. View

18.

Braeuning A, Schwarz M . Is the question of phenobarbital as potential liver cancer risk factor for humans really resolved?. Arch Toxicol. 2016; 90(6):1525-6. DOI: 10.1007/s00204-016-1712-0. View

19.

Hammad S, Hoehme S, Friebel A, von Recklinghausen I, Othman A, Begher-Tibbe B . Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis. Arch Toxicol. 2014; 88(5):1161-83. PMC: 3996365. DOI: 10.1007/s00204-014-1243-5. View

20.

Campos G, Schmidt-Heck W, Ghallab A, Rochlitz K, Putter L, Medinas D . The transcription factor CHOP, a central component of the transcriptional regulatory network induced upon CCl4 intoxication in mouse liver, is not a critical mediator of hepatotoxicity. Arch Toxicol. 2014; 88(6):1267-80. DOI: 10.1007/s00204-014-1240-8. View